2,597
Views
16
CrossRef citations to date
0
Altmetric
Reports

Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells

, , &
Pages 199-211 | Received 15 Aug 2014, Accepted 02 Oct 2014, Published online: 14 Jan 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.